Recent Events

Bioequity Europe 2013 in Stockholm
Bioequity Europe 2013 in Stock ...

May 22-23, 2013. Francois Conquet CEO of Prexton Therapeutics presented the company durin ...

Learn More
Prexton opts for Parkinson drug
Prexton opts for Parkinson dru ...

23.01.2013 - Merck-Serono spin-out Prexton Therapeutics has secured an exclusive licence o ...

Learn More
J.P. MORGAN HEALTHCARE CONFERENCE
J.P. MORGAN HEALTHCARE CONFERE ...

January 7-10, 2013. Prexton Therapeutics will be present at the 31st Annual J.P. Morgan H ...

Learn More
European Parkinson's Disease Standards of Care Consensus Statement
European Parkinson's Disease S ...

November 22, 2011. European Parkinson's Disease Standards of Care Consensus Statement. T ...

Learn More

Last Press Release

PREXTON THERAPEUTICS ANNOUNCE
PREXTON THERAPEUTICS ANNOUNCE

January 22, 2013. Prexton Therapeutics will  develop novel mGluR4 PAM series, via an ...

Learn More
Merck Serono Announce
Merck Serono Announce

July 30, 2012. Merck Serono announces the creation of the first spin-off company “Prexto ...

Learn More